For the first time, cancer
is making itself useful.

Introducing a breakthrough way to treat cancer.

Watch video

Turning cancer on
itself > Finally

RefleXion’s biology-guided radiotherapy (BgRT) allows us to detect and respond to signals emitted from the cancer itself, and for the first time, use them to guide immediate treatment.

Real-Time Guidance

Cancer is talking.
We’re listening.

When PET radiotracers are introduced into the body, cancer absorbs them and acts as a biological beacon, which our machine can use to track and treat cancer in real time.

Learn More About Emissions

Targeting Cancer

Good news for organs. Bad news for tumors.

Our technology aims to deliver high doses of radiation to tumors, even while in motion, for greater impact to the tumor with less dose to the surrounding tissue.

Learn About Targeting

Metastatic Disease

A world where stage is just a number.

Most patients with stage four cancer are not considered candidates for definitive radiotherapy due to the challenge of treating multiple tumors. Our breakthrough technology is challenging that and aims to treat multiple tumors, in parallel, during a single session. 

Discover the Potential

Combination Treatment

Come at cancer from every angle.

Treatment isn’t a one-size-fits-all situation. For many patients, the best treatment plan is a combination of multiple therapies. RefleXion will work together with chemotherapy, immunotherapy and targeted drugs for potentially better outcomes.

Learn About Treatment

Learn more about RefleXion

RefleXion BGRT

By combining PET-CT and radiotherapy, we're able to find and treat cancer using its own emissions.


Discover RefleXion Therapy.

Cancer Centers

See how RefleXion Therapy can play a role
in your cancer program.

Make every day count

See Available Positions


Press Releases

Jul 16 2019

RefleXion Names Industry Expert Thorsten Melcher as Chief Business Officer

HAYWARD, Calif., July 16, 2019  — RefleXionTM Medical, a biotargeting oncology company using each cancer’s unique biology as a means to destroy it, today announced that Thorsten Melcher, Ph.D., has joined the executive team in the role of Chief Business Officer. “Thorsten is a top-tier oncology industry leader with a proven track record of designing and executing […]

View All Press chevron right


May 16 2019

RefleXion featured in San Francisco Business Times – May 7th

RefleXion Medical is preparing to ramp up production of its cancer-fighting machine, which leverages positron emission tomography (PET) imaging to target cancer with radiation therapy. The Hayward-based company hopes to have FDA clearance for its medical machine by year’s end, propelled by a $60 million credit facility from Oxford Finance LLC granted earlier this month. […]

View All News chevron right


Jul 16 2019

The Cat in the Bag: Combination Therapy and Complete Metastatic Ablation

In prior posts of this blog, we have approached the story of metastatic cancer from a number of different angles. We discussed what metastatic cancer is, and why it is a deadly disease. We discussed in depth that drugs such as chemotherapy and immunotherapy are the most common treatment for metastatic cancer because they can attack both visible tumors and […]

View All Blog Posts chevron right


Let us tell you more.

Contact Us

Sign up for our
latest news and information.

Stay up to date.

Sign Up